Immunohistochemistry of 68 patients with CRC revealed a significant correlation between Beclin 1 levels and those of LC3 and 4E-BP1 and overexpression of LC3 in tumor tissues compared to normal tissues (30). This evidence concerns the gene MAP1LC3A and colorectal carcinoma.